JENBURKT PHARMACEUTICALS
|
The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 2.74.
| Share Price | ₹1,051.2 | Jul 24,2026 |
| Market Cap | ₹462.5 Cr | |
| Sales-TTM | ₹168.7 Cr | TTM-Standalone Results |
| Price/Sales | 2.74x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹462.5 Cr] as on Jul 24,2026
(/) Sales [ ₹168.7 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.74x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '2.74 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS
PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.20x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.94x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 1.67x.
How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| JENBURKT PHARMACEUTICALS | 168.7 | 2.74 | 462.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.97 | 465,711.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 18.22 | 192,376.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.49 | 188,655.0 |
| CIPLA LTD | 28,324.4 | 4.02 | 113,979.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.90 | 96,204.7 |
| MANKIND PHARMA LTD | 14,277.6 | 7.25 | 103,472.0 |
| LUPIN LTD | 27,958.0 | 3.88 | 108,340.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,613.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.62 | 88,119.1 |
| LAURUS LABS LTD | 7,269.6 | 11.91 | 86,564.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.62x |
| Max industry PS | 18.22x |
| Median industry PS | 4.07x |
| Average industry PS | 7.19x |
You may also like the below Video Courses